All the news Showing 10 of 102 articles from: Treatment outcomesGet an RSS feed of these articles Show All news infohep newsEditors' picks from other sources Successful hepatitis C treatment reduces portal hypertension and its complications Liz Highleyman / 27 June 2016 Direct-acting antiviral therapy for hepatitis C that produces a sustained virological response can lead to reduction in portal vein pressure, which causes some of the most serious complications of cirrhosis, according to a ... Harvoni produces high SVR rates in real-world cohort of veterans Healio Hepatology / 15 June 2016 Study Finds Patients with Hepatitis C Have Higher Hospitalization Rate MD Magazine / 31 May 2016 Low-cost generic hepatitis C drugs match branded products in viral responses Keith Alcorn / 16 April 2016 Generic versions of direct-acting antivirals purchased from China and India by people unable to obtain treatment in their own countries were just as effective and safe as the branded products, a study ... One year after universal HCV treatment, Portugal shows 96% SVR rate Healio Hepatology / 14 April 2016 Clinical impact of effective HCV DAAs: referrals for liver transplant drop after their introduction Keith Alcorn / 04 December 2015 The number of hepatitis C virus (HCV)-related referrals for liver transplant has declined significantly since the introduction of HCV direct-acting antivirals (DAAs), according to two US studies presented to the recent 2015 ... Liver fibrosis improves after successful treatment for hepatitis C Liz Highleyman / 02 December 2015 A majority of people with chronic hepatitis C and advanced fibrosis or cirrhosis showed improvement in liver health following treatment, according to study findings presented last week at the 2015 AASLD Liver ... Liver fibrosis improves after successful treatment for hepatitis C Liz Highleyman / 23 November 2015 A majority of people with chronic hepatitis C and advanced fibrosis or cirrhosis showed improvement in liver health following treatment, according to study findings presented last week at the 2015 AASLD Liver ... Liver cancer risk will remain elevated for people with cirrhosis cured of hepatitis C Keith Alcorn / 16 November 2015 The burden of liver cancer and cirrhosis caused by hepatitis C is likely to continue to grow in the United States despite curative treatment for hepatitis C, and people who have cirrhosis ... Ongoing Real World Study Reports High Sustained Viral Response Rates with VIEKIRAX® + EXVIERA® in Genotype 1 Hepatitis C Patients AbbVie press release / 14 September 2015 ← Prev1...56789...11Next → Other pages in this section Latest news All the news Hepatitis A Hepatitis B Hepatitis C Hepatitis D Hepatitis E Coronavirus NAFLD Treatment for hepatocellular carcinoma Transmission, epidemiology and prevention Health services, policy and advocacy Social issues Conference news Email bulletin archive